Longwood Fund II L.P. 13D and 13G filings for KalVista Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2022-02-10 5:11 pm Sale | 2021-02-09 | 13D | KalVista Pharmaceuticals, Inc. KALV | Longwood Fund II L.P. | 7,801 0.030% | -926,683 (-99.17%) | Filing |